• 2027 Negotiated Drug Prices Potentially Start Lower?

  Published On: 05/06/2024

• Drugs to Watch: CO, MD, OR Drug Boards

  Published On: 05/03/2024

• FTC Announces July-Ish PBM Study Results

  Published On: 04/26/2024

• Anti China Biotech Legislation: Is The Damage Done?

  Published On: 04/22/2024

• AHIP Speaks to MA 2025 Rate & Policy Environment

  Published On: 04/17/2024

• MA Rates Flat For 2025

  Published On: 04/01/2024

• Medicare Obesity Coverage Loophole

  Published On: 03/20/2024

• Biden Healthcare Budget Wish List

  Published On: 03/11/2024

• President Biden’s State of the Union

  Published On: 03/07/2024

• Anti-China Legislation Passes Senate Cmte as EO is Signed & CEOs Testify Today

  Published On: 03/07/2024

• Super Tuesday Cements November Match-Up

  Published On: 03/06/2024

• Biden EO Places More Controls on Chinese Genomics Companies

  Published On: 03/01/2024

• Healthcare (Still) Likely Minimal in CR

  Published On: 02/26/2024

• A Closer Look at South Carolina Results

  Published On: 02/25/2024

• CO Seeks Upper Payment Limit for Enbrel

  Published On: 02/23/2024

• PhRMA Negotiation Lawsuit Dismissed in TX Court

  Published On: 02/13/2024

• Pill Penalty Fix Bill (9-to-13) Unlikely to Pass

  Published On: 02/06/2024

• CMS Price Offers Going Out As R&D Expensing Bipartisan Vote Takes Place Tonight

  Published On: 01/31/2024

• MA Rates: -0.16% Without Risk Score Growth

  Published On: 01/31/2024

• Cell & Gene Therapy CMS Model Prioritizes Sickle Cell

  Published On: 01/30/2024

Previous131415Next